|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2005;79:384
© 2005 The Society of Thoracic Surgeons
Allegheny General Hospital, Department of Cardiothoracic Surgery, 320 E North Ave, South Tower, 14th Floor, Pittsburgh, PA 15212, USA
tbirdas1{at}aol.com
To the Editor:
In their article on the outcomes of pneumonectomy for stage I nonsmall cell lung cancer, Alexiou and colleagues [1] conclude that "pneumonectomy for stage T1N0 or T2N0 nonsmall cell lung cancer has a potent, adverse impact on survival." Indeed this is a very interesting finding.
As the authors point out in the "Discussion" section, lack of information on disease recurrence and cause of death do not allow for more specific conclusions and generation of hypotheses regarding the reasons for the decreased survival in the pneumonectomy group.
Another interesting question is whether early or late survival rates are equally affected, particularly because the pneumonectomy patients experienced significantly higher perioperative mortality rates. Here the authors comment that "the survival difference continues to increase over the first 2 or 3 postoperative years [1]." However this is not evident from the data presented; in fact all three survival curves shown have overlapping 95% confidence intervals at 3 and 5 years. Perhaps an alternative way of presenting the data would be the use of hazard function analysis [2] or even simply excluding the perioperative deaths. Although the significance of the findings on overall mortality should not be underestimated, separating early and late components of the mortality risk is very important in our decision making and care of these patients.
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |